Can lamotrigine cause syndrome of inappropriate antidiuretic hormone secretion (SIADH)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 27, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Lamotrigine Cause SIADH?

Yes, lamotrigine can cause syndrome of inappropriate antidiuretic hormone secretion (SIADH), though it is a less commonly recognized cause compared to other antiepileptic drugs like carbamazepine and oxcarbazepine.

Evidence Supporting the Association

The 2019 American Geriatrics Society Beers Criteria does not specifically list lamotrigine among drugs associated with hyponatremia or SIADH, though it does mention that tramadol was added to this list 1. However, the absence from this guideline does not exclude the association, as the guideline focuses primarily on geriatric populations and common offenders.

Case reports and clinical evidence demonstrate that lamotrigine can trigger SIADH, sometimes with fatal consequences. A 2018 case report documented a 35-year-old woman with bipolar disorder who died from unrecognized SIADH after lamotrigine was prescribed alongside paliperidone, with symptoms of nausea, vomiting, and thirst developing after dose escalation 2. This case emphasizes that early symptoms are often atypical and may not be spontaneously reported by patients.

Mechanism and Clinical Context

Lamotrigine shares similar mechanisms of action with carbamazepine—both act on voltage-sensitive sodium channels and decrease calcium conductance 3. Since carbamazepine is well-established as causing SIADH through central mechanisms, lamotrigine likely produces similar effects on fluid balance through centrally mediated pathways 3.

Two additional cases of sudden death in epilepsy patients on oxcarbazepine and vigabatrin (with one also receiving lamotrigine) were associated with SIADH, presenting with pulmonary edema at autopsy 4. While polypharmacy complicates attribution in these cases, the pattern suggests lamotrigine contributes to SIADH risk, particularly when combined with other antiepileptic drugs.

Clinical Implications and Monitoring

Monitor for early warning signs:

  • Nausea and vomiting
  • Headache
  • Thirst
  • Lethargy or altered mental status
  • Lack of attention or depressed mood

Check serum sodium levels:

  • At baseline before initiating lamotrigine
  • After dose escalations
  • When patients develop unexplained neurological or gastrointestinal symptoms
  • Particularly in patients on multiple psychotropic medications or other antiepileptic drugs

Common Pitfalls

The primary danger is failure to recognize early symptoms, which are nonspecific and easily attributed to other causes. The atypical presentation (nausea, vomiting, thirst) may be dismissed as medication side effects rather than investigated as potential SIADH 2. This delay in recognition can be lethal, as demonstrated in the fatal case report.

Polypharmacy increases risk significantly. When lamotrigine is combined with antipsychotics (particularly paliperidone) or other antiepileptic drugs known to cause SIADH (carbamazepine, oxcarbazepine), the risk appears substantially elevated 2, 4.

Risk Stratification

Higher risk patients include those:

  • On multiple psychotropic medications
  • Taking other antiepileptic drugs (especially carbamazepine or oxcarbazepine)
  • With baseline hyponatremia
  • Elderly patients
  • Those with cranial diabetes insipidus (paradoxically may have altered desmopressin requirements) 3

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.